Omkar Speciality Chemicals Ltd

Omkar Spl.Chem. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Omkar Speciality Chemicals Ltd

₹ 7.93 -5.03%
23 Dec - close price
omkarchemicals.com BSE: 533317 NSE: OMKARCHEM
About

Incorporated in 1993, Omkar Specialty Chemicals Ltd is engaged in the manufacture and sale of Specialty Chemicals and Pharma Intermediates for Chemical and Allied Industries.

Key Points

Product Portfolio:[1]
Company manufactures range of Organic, Inorganic and Intermediates, comprising 90+ products. These includes inorganic intermediates like derivatives of Molybdenum, Selenium, Iodine, Cobalt, and Bismuth; organic intermediates like Tartaric acid derivatives and various other organic inorganic intermediates like Iodobenzene Diacetate, Dess Martin Periodinane, Vanadyl Sulphate etc.
a) Iodine Derivatives[2]
b) Advance Intermediates[3]
c) Selenium Derivatives[4]
d) Resolving Agent[5]

Website BSE NSE - BZ
  • Market Cap ₹ 16.3 Cr.
  • Current Price ₹ 7.93
  • High / Low ₹ 11.6 / 5.65
  • Stock P/E
  • Book Value ₹ -83.0
  • Dividend Yield 0.00 %
  • ROCE -10.5 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 58.0 to 32.6 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -40.8% over past five years.
  • Contingent liabilities of Rs.13.1 Cr.
  • Working capital days have increased from 137 days to 285 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
10.70 18.97 14.43 12.79 5.14 16.86 12.16 10.97 7.36 4.23 6.34 5.05 3.74
10.31 17.88 14.10 14.83 4.86 13.80 9.20 10.78 7.76 6.55 6.21 8.16 4.69
Operating Profit 0.39 1.09 0.33 -2.04 0.28 3.06 2.96 0.19 -0.40 -2.32 0.13 -3.11 -0.95
OPM % 3.64% 5.75% 2.29% -15.95% 5.45% 18.15% 24.34% 1.73% -5.43% -54.85% 2.05% -61.58% -25.40%
0.31 0.04 0.01 0.08 1.01 0.07 0.55 4.16 0.02 0.72 0.01 0.21 0.12
Interest 1.15 1.24 1.47 1.08 1.25 1.59 1.52 1.21 1.43 1.49 1.57 1.58 1.69
Depreciation 1.69 1.66 1.98 1.25 1.03 0.98 0.98 0.57 0.47 0.47 0.40 0.44 0.39
Profit before tax -2.14 -1.77 -3.11 -4.29 -0.99 0.56 1.01 2.57 -2.28 -3.56 -1.83 -4.92 -2.91
Tax % 1.40% 67.23% 31.51% 26.11% 34.34% 71.43% 39.60% -0.39% 0.00% 0.00% 0.00% 0.00% 0.00%
-2.17 -2.96 -4.09 -5.42 -1.34 0.16 0.61 2.58 -2.28 -3.56 -1.84 -4.92 -2.90
EPS in Rs -1.05 -1.44 -1.99 -2.63 -0.65 0.08 0.30 1.25 -1.11 -1.73 -0.89 -2.39 -1.41
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
107 167 202 210 193 319 317 198 43 57 45 23 19
85 134 165 177 164 274 259 241 44 57 38 29 26
Operating Profit 21 33 36 33 29 45 57 -43 -1 -0 7 -6 -6
OPM % 20% 20% 18% 16% 15% 14% 18% -22% -3% -0% 16% -25% -32%
1 4 6 6 5 9 -161 -49 12 0 5 1 1
Interest 5 8 7 12 11 17 22 26 15 5 6 6 6
Depreciation 2 6 6 6 2 4 11 8 8 7 4 2 2
Profit before tax 15 23 29 21 20 33 -137 -127 -12 -11 3 -13 -13
Tax % 31% 29% 28% 30% 12% 33% -20% -18% 46% 29% 36% 0%
10 16 21 15 18 22 -109 -104 -17 -15 2 -13 -13
EPS in Rs 5.17 8.39 10.61 7.45 8.70 10.78 -53.09 -50.47 -8.19 -7.10 0.98 -6.12 -6.42
Dividend Payout % 19% 15% 14% 20% 17% 14% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -18%
5 Years: -41%
3 Years: -19%
TTM: -59%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 16%
TTM: -345%
Stock Price CAGR
10 Years: -20%
5 Years: 15%
3 Years: -42%
1 Year: -6%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity Capital 20 20 20 20 21 21 21 21 21 21 21 21
Reserves 73 86 107 118 142 161 -23 -146 -169 -183 -179 -192
45 78 118 154 176 186 181 233 230 233 228 226
35 33 38 50 50 80 129 28 26 26 17 18
Total Liabilities 172 217 283 342 389 447 307 136 107 97 86 72
21 36 44 43 68 78 83 76 68 53 28 26
CWIP 18 31 40 69 107 113 0 0 0 0 0 0
Investments 1 2 11 14 14 14 0 11 0 0 1 0
133 148 187 217 199 242 224 49 38 44 58 46
Total Assets 172 217 283 342 389 447 307 136 107 97 86 72

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
4 -0 0 24 53 -9 107 26 1 4 -16 1
-45 -32 -46 -43 -76 12 -120 -64 11 2 17 0
82 22 36 15 17 -8 16 35 -14 -5 -1 -1
Net Cash Flow 41 -10 -10 -3 -6 -6 3 -3 -1 0 -0 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 93 84 111 148 129 117 90 19 74 30 111 33
Inventory Days 147 168 170 156 149 99 110 8 37 31 18 40
Days Payable 106 81 73 94 96 81 184 32 259 148 139 215
Cash Conversion Cycle 135 172 209 210 181 135 16 -5 -147 -86 -10 -143
Working Capital Days 180 156 183 184 139 148 48 -26 -119 -38 165 285
ROCE % 22% 19% 17% 12% 10% 14% 18% -34% -8% -8% 7% -11%

Shareholding Pattern

Numbers in percentages

Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022
27.62% 27.62% 27.62% 27.62% 27.62% 27.62% 14.71% 27.62% 17.62% 17.62% 14.71% 14.71%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.00% 0.01% 0.00% 0.06% 0.06%
0.01% 0.03% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00% 0.01% 0.01% 0.01%
72.38% 72.35% 72.38% 72.38% 72.38% 72.38% 85.22% 72.38% 82.36% 82.37% 85.22% 85.22%
No. of Shareholders 19,72819,50719,08718,96518,67818,27319,43017,46119,15219,31819,43019,430

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls